About tactile systems technology inc - TCMD
Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. It provides lymphedema solutions and offers Flexitouch Plus and Entre Plus systems products. The company was founded on January 30, 1995 and is headquartered in Minneapolis, MN.
TCMD At a Glance
Tactile Systems Technology, Inc.
3701 Wayzata Boulevard
Minneapolis, Minnesota 55416
| Phone | 1-612-355-5100 | Revenue | 329.52M | |
| Industry | Medical Specialties | Net Income | 19.09M | |
| Sector | Health Technology | 2025 Sales Growth | 12.471% | |
| Fiscal Year-end | 12 / 2026 | Employees | 1,086 | |
| View SEC Filings |
TCMD Valuation
| P/E Current | 32.143 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 35.396 |
| Price to Sales Ratio | 2.05 |
| Price to Book Ratio | 2.973 |
| Price to Cash Flow Ratio | 15.78 |
| Enterprise Value to EBITDA | 16.928 |
| Enterprise Value to Sales | 1.845 |
| Total Debt to Enterprise Value | 0.026 |
TCMD Efficiency
| Revenue/Employee | 303,427.256 |
| Income Per Employee | 17,574.586 |
| Receivables Turnover | 5.526 |
| Total Asset Turnover | 1.131 |
TCMD Liquidity
| Current Ratio | 4.033 |
| Quick Ratio | 3.69 |
| Cash Ratio | 2.037 |
TCMD Profitability
| Gross Margin | 75.17 |
| Operating Margin | 8.885 |
| Pretax Margin | 9.51 |
| Net Margin | 5.792 |
| Return on Assets | 6.553 |
| Return on Equity | 8.765 |
| Return on Total Capital | 8.127 |
| Return on Invested Capital | 7.831 |
TCMD Capital Structure
| Total Debt to Total Equity | 7.29 |
| Total Debt to Total Capital | 6.795 |
| Total Debt to Total Assets | 5.716 |
| Long-Term Debt to Equity | 5.83 |
| Long-Term Debt to Total Capital | 5.434 |